Diabetic Retinopathy Market 2019 Growth Analysis by Product, Application, Industry Players and Regional Outlook 2025
Category: #health  By Partha Ray  Date: 2019-09-04
  • share
  • Twitter
  • Facebook
  • LinkedIn

Diabetic Retinopathy Market 2019 Growth Analysis by Product, Application, Industry Players and Regional Outlook 2025

Diabetic Retinopathy Market Size was valued at USD 8 billion in 2018 and is expected to witness 6.9% CAGR from 2019 to 2025.

The growing prevalence of diabetes and its hazardous side-effects is one of pivotal factors responsible for diabetic retinopathy market expansion. Subject to sedentary lifestyles, in recent times, there has been a major rise in obesity, which has subsequently led to an increase in the number of diabetic issues. It has been observed that complications related to diabetes have been increasing massively, primarily on account of late diagnosis. In this regard, most of the regional governments are organizing awareness programs to encourage people to carry out eye screening tests for averting diabetic retinopathy, which would further demand appropriate treatment methods, pushing diabetic retinopathy industry share over the years ahead. The availability of artificial intelligence assisted healthcare services is also expected to impel diabetic retinopathy industry share, driven by the efficient and effective deployment of this technology for eye screening. As per estimates, diabetic retinopathy market share is expected to surpass USD 12 billion by 2025.

Request for a sample of this research report @  https://www.gminsights.com/request-sample/detail/486

Company profiled in this report based on Business overview, Financial data, Product landscape, Strategic outlook & SWOT analysis:
1. Bayer Healthcare
2. Novartis AG
3. Regeneron Pharmaceuticals Inc.
4. Allergan plc
5. ThromboGenics NV
6. Sirnaomics, Inc.
7. Genentech
8. Alimera Sciences
9. Ampio Pharmaceuticals

10. BCN Peptides

Vision loss stands as one of the most problematic health issues as on today. As per the CDC (Center for Disease Control and Prevention) vision problems accounted for USD 51.4 billion in treatments, for the United States on an annual basis. Yearly, around 12,000 to 24,000 new cases of blindness due to diabetic retinopathy occur in U.S. In consequence, the government is looking forward to deploying cost-effective and efficient screening tests for diabetic patients, which would undeniably fuel U.S. diabetic retinopathy industry share.

Speaking along the same lines, in first half of 2017, the FDA (Food and Drug Administration) also contributed majorly to U.S. diabetic retinopathy market share by approving the Lucentis (ranibizumab) injection for all kinds of diabetic retinopathy. Post the clinical trials, the analysis results depicted that 37.8% patients witnessed better improvement in diabetic retinopathy. Given that this is one of the most prominent causes of blindness across the U.S. among the working populace aged between 20 and 74, this approval has proved to be rather beneficial for diabetic retinopathy industry. The increasing demand for Lucentis injection for treating eye retina problems is cited to have a substantial impetus on diabetic retinopathy market share.

In order to deal with the increasing prevalence of blindness caused due to diabetic retinopathy, several players in diabetic retinopathy industry, in tandem with tech giants are investing heavily in software-based diagnosis methodologies. For instance, IDx, a medical device firm working on the development of software-based healthcare tools has invented an AI-based screening test for diabetic retinopathy. At present, it is under FDA clinical trial to obtain clearance for its use across U.S., post which it may bring about a revolution in U.S. diabetic retinopathy industry.

Browse Report Summary @ https://www.gminsights.com/industry-analysis/diabetic-retinopathy-market-report

In many countries though, where diabetic screening programs are not yet a reality, renowned tech giants and researchers are working continuously to introduce a series of screening programs. For instance, the research team of Google has developed an AI based diagnostic tool for detecting diabetic retinopathy, which is under clinical trial for being available across India. According to International Diabetes Federation, by 2045, India is predicted to have 134mn cases of diabetes, which is higher than the projected number of China (120 million). Undeniably, this would offer lucrative opportunities for participants in diabetic retinopathy market for business expansion across India.

Meanwhile, the escalating implementation of government approved fundraising and social welfare programs for blindness control has also been forecast to propel diabetic retinopathy market trends over the years ahead. Additionally, financial assistance from worldwide healthcare-related organizations such as WHO, DANIDA, and World Bank for the betterment of blindness programs will stimulate diabetic retinopathy industry trends. Driven by the increasing availability of advanced treatment facilities at the affordable prices, diabetic retinopathy market size will indeed chart out a lucrative path over 2019-2025.

More Insightful Info @ https://www.marketwatch.com/press-release/diabetic-retinopathy-market-2019-size-global-industry-report-forecast-to-2025-2019-05-20

About Global Market Insights:

Global Market Insights, Inc., headquartered in Delaware, U.S., is a global market research and consulting service provider; offering syndicated and custom research reports along with growth consulting services. Our business intelligence and industry research reports offer clients with penetrative insights and actionable market data specially designed and presented to aid strategic decision making. These exhaustive reports are designed via a proprietary research methodology and are available for key industries such as chemicals, advanced materials, technology, renewable energy and biotechnology.

Contact Us:

Arun Hegde

Corporate Sales, USA

Global Market Insights, Inc.

Phone:1-302-846-7766

Toll Free: 1-888-689-0688

Email: [email protected]

Web: www.gminsights.com/

  • share
  • Twitter
  • Facebook
  • LinkedIn


About Author

Partha Ray    

Partha Ray

Partha is into digital marketing since the last 3 years and has worked on multiple projects across various industries. An Computer Science engineer by education, he has prior experience in software development. His other interests include playing cricket & Hockey.

...

Read More

More News By Partha Ray

Medical Tuning Fork Market 2019| Application and Future Forecast by 2025
Medical Tuning Fork Market 2019| Application and Future Forecast by 2025
By Partha Ray

Medical Tuning Fork Market size is expected to grow significantly from 2019 to 2025. Medical tuning fork market is estimated to witness lucrative growth in the forthcoming years owing to growing geriatric population susceptible to hearing loss. Medic...

Krill Oil Market 2019 By Industry Trends, Statistics, Key Companies Growth and Regional Forecast To 2025
Krill Oil Market 2019 By Industry Trends, Statistics, Key Companies Growth and Regional Forecast To 2025
By Partha Ray

Krill oil market report provides a comprehensive landscape of the industry, accurate market estimates and forecast split by product, application, technology, region and end-use. All quantitative information is covered on a regional as well as country...

Refined Functional Carbohydrates Market 2019 Trends, Growth Analysis, Forecast 2025
Refined Functional Carbohydrates Market 2019 Trends, Growth Analysis, Forecast 2025
By Partha Ray

Global Market Insights, Inc. provides a detailed overview of Refined Functional Carbohydrates market with respect to the pivotal drivers influencing the revenue graph of this business sphere. The current trends of market in conjunction with the geogr...